Almost all individuals with NF1 will fulfil clinical criteria for the diagnosis by age 8 years.
Around half of children with NF1 who do not have a known family history of NF1 will fulfil clinical diagnostic criteria by age one year.
Transferred to new eviQ website. Version change to V.2.
Previous website ID: 355
Neurofibromatosis 1 (NF1) is an inherited neurocutaneous disease that has a major impact on the nervous system, eye, skin, and bone. Individuals with NF1 have a predisposition to benign and malignant tumor formation and the hallmark lesion is the neurofibroma, a benign peripheral nerve sheath tumor. The gene for NF1 was cloned on chromosome 17q11.2 and neurofibromin, the NF1 protein, controls cell growth and proliferation by regulating the proto-oncogene Ras and cyclic adenosine monophosphate (AMP). Advances in molecular biology and mouse models of disease have enhanced our understanding of the pathogenesis of NF1 complications and facilitated targeted therapy. Progress has been made in developing robust clinical and radiological outcome measures and clinical trials are underway for children with learning difficulties and for individuals with symptomatic plexiform neurofibromas.
Send feedback for this page
The currency of this information is guaranteed only up until the date of printing, for any updates please check:
18 Sep 2019